Loading
No insider purchase over the last 90 days. The latest, by Jemmy Kurniawan, was filed 22 Jan 2024.
PT Hetzer Medical Indonesia Tbk is a listed company. Its directors and officers file their transactions with OJK / IDX. From 23 October 2025 to 23 October 2026, the disclosure feed for PT Hetzer Medical Indonesia Tbk logged 2 filings by 1 insider.
All open-market trades in the period are sales: 2 sales worth €6,304, by 1 insider, with no purchase on record. At €4,605, the sale published on 4 December 2025 by Jemmy Kurniawan is the largest of the period.
With 2 filings in twelve months, the company is quieter than the median of 3 filings across the 301 companies we follow on the same exchange. The full history, which starts in 2024, counts 1 purchase against 3 sales.
Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification.
This summary is built from OJK / IDX disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
4 of 4 declarations
PT Hetzer Medical Indonesia Tbk is a publicly traded company on the XIDX market, specializing in the medical sector in Indonesia.